Cargando…
Single-cell transcriptomics of human iPSC differentiation dynamics reveal a core molecular network of Parkinson’s disease
Parkinson’s disease (PD) is the second-most prevalent neurodegenerative disorder, characterized by the loss of dopaminergic neurons (mDA) in the midbrain. The underlying mechanisms are only partly understood and there is no treatment to reverse PD progression. Here, we investigated the disease mecha...
Autores principales: | Novak, Gabriela, Kyriakis, Dimitrios, Grzyb, Kamil, Bernini, Michela, Rodius, Sophie, Dittmar, Gunnar, Finkbeiner, Steven, Skupin, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758783/ https://www.ncbi.nlm.nih.gov/pubmed/35027645 http://dx.doi.org/10.1038/s42003-021-02973-7 |
Ejemplares similares
-
Generation of two human induced pluripotent stem cell lines (iPSCs) with mutations of the α-synuclein (SNCA) gene associated with Parkinson’s disease; the A53T mutation (LCSBi003) and a triplication of the SNCA gene (LCSBi007)
por: Novak, Gabriela, et al.
Publicado: (2021) -
Transcriptome Dynamics of Human Neuronal Differentiation From iPSC
por: Kuruş, Meltem, et al.
Publicado: (2021) -
Distinct and Dynamic Transcriptome Adaptations of iPSC-Generated Astrocytes after Cytokine Stimulation
por: Spreng, Anna-Sophie, et al.
Publicado: (2022) -
Extensive reprogramming of the nascent transcriptome during iPSC to hepatocyte differentiation
por: Viiri, Leena E., et al.
Publicado: (2019) -
Huntington’s disease iPSC models—using human patient cells to understand the pathology caused by expanded CAG repeats
por: Kaye, Julia, et al.
Publicado: (2022)